v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash equivalents $ 229,394 $ 6,081
Due From Sponsor 192,493 0
Prepaid expense 34,554 0
Prepaid insurance 85,400 0
Total Current Assets 541,841 6,081
Deferred offering costs 0 587,984
Cash and marketable securities held in Trust Account 174,896,125 0
TOTAL ASSETS 175,437,966 594,065
Current liabilities    
Accrued expenses 890,106 60,417
Accrued offering costs 208,270 401,313
Promissory note – related party 0 217,513
Total Current Liabilities 1,098,376 679,243
Deferred underwriting fee payable 12,075,000 0
Total Liabilities 13,173,376 679,243
Class A Ordinary Shares subject to possible redemption, 17,250,000 and 0 shares at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31,2025, respectively 174,896,125 0
Shareholders' Deficit    
Preference shares 0 0
Additional paid-in capital 0 24,425
Accumulated deficit (12,632,215) (110,178)
Total Shareholders' Deficit (12,631,535) (85,178)
Total Liabilities and Shareholder's Deficit 175,437,966 594,065
Class A Ordinary Shares [Member]    
Shareholders' Deficit    
Common stock value 105 0
Class B Ordinary Shares [Member]    
Shareholders' Deficit    
Common stock value $ 575 $ 575 [1]
[1] This number includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On February 6, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor (Note 4).